Menu
Back to User profile » Dr Litao Xu
Papers published by Dr Litao Xu:
Overexpression of a Long Non-Coding RNA BC037916 is Associated with Pancreatic Tumorigenesis and Poor Prognosis
Chen G, Xu L, Ye G, Lin J, Meng Z, Shen Y
OncoTargets and Therapy 2020, 13:13451-13463
Published Date: 5 January 2021
ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways
Shen Y, Chen G, Zhuang L, Xu L, Lin J, Liu L
OncoTargets and Therapy 2019, 12:5003-5012
Published Date: 28 June 2019
High-intensity focused ultrasound enhances the effect of bufalin by inducing apoptosis in pancreatic cancer cells
Ning Z, Zhu Z, Wang H, Zhang C, Xu L, Zhuang L, Yan X, Wang D, Wang P, Meng Z
OncoTargets and Therapy 2019, 12:1161-1170
Published Date: 12 February 2019
HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients
Ning Z, Xie J, Chen Q, Zhang C, Xu L, Song L, Meng Z
OncoTargets and Therapy 2019, 12:1021-1029
Published Date: 1 February 2019
Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma
Zhu Z, Xu L, Zhuang L, Ning Z, Zhang C, Yan X, Lin J, Shen Y, Wang P, Meng Z
OncoTargets and Therapy 2018, 11:6731-6740
Published Date: 10 October 2018
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2017, 10:1441-1449
Published Date: 6 March 2017
Prognostic nutritional index serves as a predicative marker of survival and associates with systemic inflammatory response in metastatic intrahepatic cholangiocarcinoma
Zhang C, Wang H, Ning Z, Xu L, Zhuang L, Wang P, Meng Z
OncoTargets and Therapy 2016, 9:6417-6423
Published Date: 19 October 2016